Nicolas Blondiaux

Reversion of antibiotic resistance in <i>Mycobacterium tuberculosis</i> by spiroisoxazoline SMARt-420

Nicolas Blondiaux, Martin Moune, Matthieu Desroses et al. · Science · 2017 · 143 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors

Marion Flipo, Matthieu Desroses, Nathalie Lecat‐Guillet et al. · Journal of Medicinal Chemistry · 2011 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Ligand Efficiency Driven Design of New Inhibitors of <i>Mycobacterium tuberculosis</i> Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches

Baptiste Villemagne, Marion Flipo, Nicolas Blondiaux et al. · Journal of Medicinal Chemistry · 2014 · 64 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Daily serum piperacillin monitoring is advisable in critically ill patients

Nicolas Blondiaux, Raphaël Favory, Thierry Onimus et al. · International Journal of Antimicrobial Agents · 2010 · 52 citations · Full text

Medicine, Pharmacotherapy, Critical Care Medicine +7

Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations

E. Fiaux, Marie Titécat, Olivier Robineau et al. · BMC Infectious Diseases · 2016 · 51 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17